
Sign up to save your podcasts
Or


Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.

321 Listeners

39 Listeners

65 Listeners

30 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

1,150 Listeners

46 Listeners

2 Listeners

367 Listeners

53 Listeners

59 Listeners

51 Listeners

195 Listeners

45 Listeners

30 Listeners

0 Listeners